Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orphan Disease Natural History Grants Latest FDA Incentive For Drug Development

07 Mar 2016

• By Derrick Gingery

Agency will make $2m available in 2017.

Related Content

Rare Disease R&D: FDA To Use NIH Registry For Natural History Studies

16 Apr 2012

Rare Diseases Need Ongoing Natural History Studies To Speed Trials, FDA Says

14 Nov 2011

Additional Topics

United States Clinical Trials Research & Development BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.